Mangoceuticals, Inc.
MGRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $481 | $101 | $76 | $59 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $117 | $17 | $100 | $17 |
| Total Curr. Assets | $598 | $118 | $177 | $76 |
| Property Plant & Equip (Net) | $13 | $30 | $46 | $62 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15,920 | $20,695 | $21,531 | $15,233 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $15,934 | $20,725 | $21,577 | $15,295 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $16,532 | $20,843 | $21,754 | $15,371 |
| Liabilities | – | – | – | – |
| Payables | $0 | $768 | $1,178 | $838 |
| Short-Term Debt | $212 | $630 | $48 | $215 |
| Tax Payable | $0 | $3 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $592 | $200 | $277 | $373 |
| Total Curr. Liab. | $804 | $1,601 | $1,503 | $1,425 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $30 | $48 | $65 |
| Total Liabilities | $804 | $1,601 | $1,503 | $1,425 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $0 |
| Retained Earnings | -$37,878 | -$31,650 | -$25,940 | -$20,807 |
| AOCI | -$2 | -$2 | -$2 | -$10 |
| Other Equity | $53,608 | $50,894 | $46,193 | $34,762 |
| Total Equity | $15,729 | $19,243 | $20,252 | $13,946 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$2 | -$1 | -$1 | -$1 |
| Total Liab. & Tot. Equity | $16,532 | $20,843 | $21,754 | $15,371 |
| Net Debt | -$269 | $529 | -$29 | $156 |